iGENE 2.0: Mapping the Genetics of Vision and Advancing the Future of Ocular Genetics
Published 30th January 2026
The iGENE 2.0: Mapping the Genetics of Vision conference, held at L V Prasad Eye Institute’s Kallam Anji Reddy Campus, Hyderabad, on January 24 & 25, 2026, concluded successfully with wide engagement and knowledge exchange across disciplines.
The 2026 edition brought together clinicians, researchers, genetic counselors, and students who share a deep interest in the evolving field of ocular genetics. The conference built on its core purpose of integrating genetics into everyday clinical ophthalmology, enabling participants to understand emerging trends and apply them in real‑world settings.
Sessions offered a comprehensive overview of ocular genetics, from fundamentals to advanced applications, linking molecular insights with clinical decision‑making. Discussions covered a spectrum of eye genetic disorders, detailing approaches to diagnosis, management, and long-term patient care!
Experts addressed the role of prenatal testing, genetic counseling, and the expanding possibilities of gene and cell-based therapies, bringing new hope for families affected by rare ocular conditions. National and international perspectives highlighted the growing importance of genetic counselors in patient care pathways.
Participants engaged with sessions on:
– Eye disorders with systemic associations
– Developmental ocular anomalies
– Molecular diagnostics
– Forward-looking therapeutic strategies
Case-based discussions and free paper presentations enriched the learning experience by showcasing diverse clinical scenarios.
The hybrid format ensured wide engagement, with 101 onsite participants, including 41 expert speakers, and 43 virtual attendees joining from different regions.
iGene 2.0 further reinforced the pressing need for integrating genomic medicine into mainstream ophthalmic practice. The collaborative discussions, expert insights, and shared experiences have laid the groundwork for more robust clinical–research partnerships in the years ahead.
The conference concluded with a renewed commitment to:
– Enhance early and accurate diagnosis of inherited eye diseases
– Improve access to genetic testing and counseling
– Accelerate the translation of innovations into patient care
